PRRT2 and Alzheimer disease: Consistent with the involvement of PKC in the pathology of AD, unbiased phosphoproteomics studies have identified augmented phosphorylation of PKC substrates, including myristoylated alanine-rich C-kinase substrate (MARCKS), as one of the main events in AD development29,30.